Skip to main content


Dr. Ginsburg first began performing MOHS surgery in 1999 at our Montclair office. Since then Dr. Ginsburg has performed thousands of MOHS procedures in Birmingham, Alabama.
Mohs surgery, also known as chemosurgery, was developed in Dr. Frederic E. Mohs. Mohs Surgery is microscopically controlled surgery used to treat common types of skin cancer.

During the surgery, after removal of tissue, while the patient waits, Dr. Ginsburg examines the tissue specimen for cancer cells, and that examination informs him where to remove tissue next. Dr. Ginsburg is performing the procedure and he is also the pathologist reading the specimen slides.


Mohs surgery is one of the many methods of obtaining complete margin control during removal of a skin cancer using frozen section histology. CCPDMA or Mohs surgery allows for the removal of a skin cancer with very narrow surgical margin and a high cure rate.

(CCPDMA – complete circumferential peripheral and deep margin assessment.)


The cure rate with Mohs surgery is very high. Most studies cite the cure rate as between 97% and 99.8% for primary basal cell carcinoma, the most common type of skin cancer. Mohs procedure is also used for squamous cell carcinoma, but with a lower cure rate. Two isolated studies reported cure rate for primary basal cell carcinoma as low as 95% and 96%. Recurrent basal cell cancer has a lower cure rate with Mohs surgery, more in the range of 94%. It has been used in the removal of melanoma-in-situ (cure rate 77% to 98% depending on surgeon), and certain types of melanoma (cure rate 52%). Another study of melanoma-in-situ revealed Mohs cure rate of 95% for frozen section Mohs, and 98 to 99% for fixed tissue Mohs method.

Contact Ginsburg Dermatologyin Birmingham, Alabama to schedule an appointment with Dr. Ginsburg.